Jaguar Health (JAGX) Cash from Operations (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Cash from Operations of 8830000.0 for Q1 2026, up 220.73% year-over-year from 2753117.06 in Q1 2025, and up 260.9% quarter-over-quarter from 5488000.0 in Q4 2025.
Jaguar Health (JAGX) Cash from Operations (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Cash from Operations for 13 consecutive years, with 8830000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 220.73% year-over-year to 8830000.0; the TTM figure through Mar 2026 stood at 7542000.0 (up 74.56% YoY), while the FY2025 annual figure was 23686000.0, up 19.39% from the prior year.
- Cash from Operations grew to 8830000.0 in Q1 2026 per JAGX's latest filing, from 5488000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8830000.0 in Q1 2026 and bottomed at 10457000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 6505058.82 across 5 years, with a median of 7314000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Operations declined 29.24% — and 2026, when it surged 220.73%.
- Jaguar Health's Cash from Operations stood at 6423000.0 in 2022, then declined by 16.0% to 7451000.0 in 2023, then slipped by 5.03% to 7826000.0 in 2024, then gained by 29.87% to 5488000.0 in 2025, then soared by 260.9% to 8830000.0 in 2026.
- Business Quant data shows JAGX's Cash from Operations at 8830000.0 in Q1 2026, 5488000.0 in Q4 2025, and 4689000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 8.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.83 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2025 | -5.49 Mn |
| Dec 31, 2025 | -5.49 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Sep 30, 2025 | -4.69 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Dec 31, 2024 | -7.83 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Jun 30, 2024 | -8.17 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Mar 31, 2024 | -7.05 Mn |
| Dec 31, 2023 | -7.45 Mn |
| Dec 31, 2023 | -7.45 Mn |